Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
Pakistan · Delayed Price · Currency is PKR 904.28
+4.28 (0.48%)
At close: Aug 20, 2026
PSX:ABOT Ratios and Metrics
Market cap in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 88,110 | 102,809 | 121,187 | 45,055 | 45,358 | 70,244 | |
Market Cap Growth | -23.08% | -15.17% | 168.98% | -0.67% | -35.43% | -5.01% |
Enterprise Value | 76,113 | 94,235 | 117,384 | 41,433 | 38,343 | 61,567 |
Last Close Price | 900.00 | 1007.98 | 1177.21 | 437.66 | 440.61 | 646.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.61 | 12.91 | 23.15 | 172.11 | 15.10 | 11.77 |
Forward PE | 7.65 | 13.14 | 11.12 | 11.12 | 11.12 | 11.43 |
PS Ratio | 1.16 | 1.36 | 1.78 | 0.81 | 0.92 | 1.65 |
PB Ratio | 2.62 | 3.25 | 5.11 | 2.47 | 2.65 | 4.05 |
P/TBV Ratio | 2.62 | 3.25 | 5.11 | 2.47 | 2.66 | 4.06 |
P/FCF Ratio | 14.10 | 13.82 | 73.36 | - | 213.72 | 12.18 |
P/OCF Ratio | 9.41 | 9.57 | 25.93 | - | 11.95 | 8.98 |
PEG Ratio | - | 1.39 | 1.39 | 1.39 | 1.39 | 1.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.00 | 1.25 | 1.72 | 0.75 | 0.78 | 1.45 |
EV/EBITDA Ratio | 4.92 | 6.41 | 11.32 | 10.45 | 5.20 | 6.75 |
EV/EBIT Ratio | 5.63 | 7.28 | 13.54 | 16.79 | 6.38 | 7.69 |
EV/FCF Ratio | 12.18 | 12.66 | 71.06 | - | 180.67 | 10.67 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.00 | 0.04 | 0.03 | 0.03 |
Debt / FCF Ratio | 0.08 | 0.07 | 0.03 | - | 1.17 | 0.04 |
Net Debt / Equity Ratio | -0.36 | -0.41 | -0.26 | -0.27 | -0.50 | -0.48 |
Net Debt / EBITDA Ratio | -0.78 | -0.87 | -0.59 | -1.23 | -1.16 | -0.92 |
Net Debt / FCF Ratio | -1.92 | -1.73 | -3.71 | 1.56 | -40.26 | -1.45 |
Asset Turnover | 1.69 | 1.79 | 1.83 | 1.57 | 1.58 | 1.59 |
Inventory Turnover | 3.50 | 4.00 | 3.94 | 3.95 | 4.39 | 4.34 |
Quick Ratio | 1.14 | 1.28 | 0.93 | 0.54 | 0.79 | 1.14 |
Current Ratio | 2.33 | 2.32 | 2.00 | 1.38 | 1.49 | 1.97 |
Return on Equity (ROE) | 28.59% | 28.79% | 24.95% | 1.48% | 17.44% | 36.22% |
Return on Assets (ROA) | 18.89% | 19.16% | 14.58% | 4.37% | 12.02% | 18.71% |
Return on Invested Capital (ROIC) | 39.57% | 42.02% | 32.12% | 2.28% | 33.49% | 63.48% |
Return on Capital Employed (ROCE) | 38.20% | 38.70% | 33.40% | 12.40% | 31.10% | 41.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.43% | 7.75% | 4.32% | 0.58% | 6.62% | 8.49% |
FCF Yield | 7.09% | 7.24% | 1.36% | -6.96% | 0.47% | 8.21% |
Dividend Yield | 4.44% | 3.97% | 0.85% | - | 3.40% | 6.19% |
Payout Ratio | 11.67% | 12.20% | 19.69% | 525.03% | 33.82% | 73.70% |
Total Shareholder Return | 4.45% | 3.97% | 0.85% | - | 3.40% | 6.19% |